New Treatment for Hemophilia A Now Available

Baxalta announced the launch of Adynovate (antihemophilic factor [recombinant], PEGylated), after receiving approval from the Food and Drug Administration (FDA) for on-demand treatment and control of bleeding episodes, and routine prophylaxis to reduce the frequency of bleeding episodes in patients with hemophilia A aged ≥12 years.

AAP: Guidance on Pediatric Peri-Op Anesthesia

Guidance relates to care team, resources committed to patient care, pediatric-specific techniques

Study: Basal Insulin Peglispro vs. Insulin Glargine for Glycemic Control

In T2DM, also tied to increased triglycerides, aminotransferases, and liver fat content

Drug-Induced Aseptic Meningitis Following Antibiotic Use

Case report describes 87-year-old with 3 episodes; decreasing interval between dose, symptoms

Neurotoxicity Seen With Acyclovir at Recommended Dose in Dialysis

Case report describes acyclovir-induced neurotoxicity in patient treated with recommended dose

C. Difficile Infection Tied to Higher Risk of Post-Op Mortality

Postoperative complications also increased in this patient population

Private Rooms Pay Off for Both Patients and Hospitals

Increased cost of building them is offset by decreases in additional medical care, research shows

AAFP: Guidelines for Clinicians Who Want to Become Active in Social Media

Guidelines provided for physicians wishing to become more active in social media

Updated Administration Information for Linzess

The FDA has approved a sNDA for Linzess (linaclotide; Actavis and Ironwood) to allow the capsule contents to be sprinkled in applesauce or water for adults with swallowing difficulties. Also, the FDA has approved additional instructions for patients with nasogastric or gastric feeding tubes.

Melatonin May Improve Sleep in Children With Atopic Dermatitis

Children taking melatonin fell asleep about 21 minutes sooner than those taking placebo